Citation

Rowe C, Spelman L, Oziemski M, Ryan A, Manoharan S, Wilson P, Daubney M, Scott J. Australas. J. Dermatol. 2014; 55(2): 162-167.

Copyright

(Copyright © 2014, Australasian College Of Dermatologists, Publisher John Wiley and Sons)

DOI

10.1111/ajd.12117

PMID

unavailable

Abstract

Acne is a common condition among adolescents and has the potential to negatively impact on the psychological well-being of those who suffer from it. In particular, depression and suicidal ideation are more common in adolescents with acne. Successful treatment of acne can improve the quality of life and reduce levels of anxiety and depression in these individuals. The current treatment of choice for severe or refractive acne is isotretinoin, a retinoid. While the possible causal association between isotretinoin and mental illness remains a controversial topic, a recent systematic review has presented evidence to support this relationship. In light of this evidence, a group of dermatologists and psychiatrists have collaborated to develop these recommendations to aid the safe prescribing of isotretinoin in adolescents. These clinical suggestions are aimed at practitioners in both disciplines to increase awareness of the current evidence in support of the association between isotretinoin and adolescent depression. © 2013 The Australasian College of Dermatologists.

Language: en

Keywords

Humans; adolescent; Australia; human; mental health; suicide; quality of life; Quality of Life; depression; acne; isotretinoin; review; acne vulgaris; Patient Selection; mental disease; prescription; patient monitoring; Mental Disorders; side effect; patient selection; consensus development; consensus; Dermatologic Agents; dermatological agent; Isotretinoin; Acne Vulgaris; patient assessment; chemically induced; adverse outcome; guideline